Quali sono gli orari di apertura?

Lunedì 09:00 - 18:00 Martedì 09:00 - 18:00 Mercoledì 09:00 - 18:00 Giovedì 09:00 - 18:00 Venerdì 09:00 - 18:00

Resono Ophthalmic Srl

Casa
Italia
Sandrigo
Resono Ophthalmic Srl

Resono Ophthalmic is an innovative Italian SME founded in 2014 to develop and sell cutting-edge therapeutic devices for Ophthalmology.

Resono Ophthalmic is an Italian company developing therapeutical devices for Ophthalmology based on QMR®, a patented technology that stimulates the natural regeneration of cells. The key feature of our devices is the Quantum Molecular Resonance (QMR®) treatment. It is a patented technology that stimulates the natural regeneration of cells and tissue by delivering low-power, high-frequency electrical fields. We first applied this technique to treat Dry Eye Disease (DED) with Rexon-Eye®, a patented CE-marked medical device. Clinical trials in Italy and abroad have provided scientific evidence that Rexon-Eye® is a safe, effective, and long-term treatment option for all types of DED. The benefits of QMR® in stimulating cell and tissue regeneration are currently under investigation also for its possible application in other eye diseases. For more information about technical and clinical details, please visit our website.

*QMR® is a registered trademark by Telea Electronic Engineering.

09/09/2025

The European Society of Retina Specialists (EURETINA) 2025 in Paris is now part of our history, marked by outstanding results.

A special thank you to Dr. Luigi Donato for presenting the first in-vitro study with hashtag Technology applied to Retinal Pigment Epithelium (RPE).
A promising step forward in tackling one of the most challenging areas in retinal disease.

Read the full article here: https://lnkd.in/dudqgGsE

03/09/2025

ESCRS 2025, Copenhagen - Rexon-Eye Speeches – Booth C2.090

Join us to discover the wide-ranging applications and achievements of Rexon-Eye and Technology in real-world clinical practice.

Leading experts Dr. Giovanni Roberto Tedesco , Dr. Luca Vigo MD .luca , and Dr. Andrés Benatti .benatti will present their insights and clinical experience in the management of Dry Eye.

Where:📍 Booth C2.090 at 43rd The European Society of Cataract and Refractive Surgeons (ESCRS)

Check out our program and save the dates!

02/09/2025

ESCRS 2025, Copenhagen - Rexon-Eye Speeches – Booth C2.090

Join us to discover the wide-ranging applications and achievements of Rexon-Eye and hashtag Technology in real-world clinical practice.

Leading experts Dr. Giovanni Roberto Tedesco, Dr. Luca Vigo, and Dr. Andrés Benatti will present their insights and clinical experience in the management of Dry Eye.

Where:📍 Booth C2.090 at 43rd The European Society of Cataract and Refractive Surgeons (ESCRS)

Check out our program and save the dates 👇

26/08/2025

A new achievement!

We are proud to announce that we have been selected, among numerous companies, as one of the three finalists at the ESCRS Innovation Day of The European Society of Cataract and Refractive Surgeons (ESCRS) with our QMR technology and latest development.

ESCRS iNovation® Day is a truly unique meeting. It brings together doctors, corporate executives and pioneering companies, highlighting future cutting-edge technologies and solutions for the most urgent clinical needs and barriers in the field of ophthalmology.

This achievement marks an important recognition of the wide-ranging applications of QMR and its role in redefining the future of ocular disease treatment.

👉 For more information: https://lnkd.in/gN4NjfVd

22/08/2025

🇩🇰Save the dates!

Don't miss the insight speeches from two renowned international experts, sharing their clinical experiences with Rexon-Eye.

📍 booth C2.090, The European Society of Cataract and Refractive Surgeons (ESCRS) Congress, Copenhagen

📅 13 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿:
15:00 – Dr. Giovanni Roberto Tedesco

📅 14 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿:
15:00 – Dr. Andres Benatti

12/08/2025

Muchas gracias to our Mexican distributor, EYECO, for exceptionally representing Rexon-Eye at Central Ophthalmic Congress (Santiago de Querétaro, Mexico)
Their professionalism and dedication—demonstrated by an outstanding team—made a lasting impression.
We’re proud to collaborate with such passionate partners in advancing Dry Eye care across the region.

Want more info? 👉 https://www.eyeco.com.mx/

07/08/2025

Nuova pubblicazione: Attuali trattamenti del Dry Eye

Siamo lieti di annunciare l'uscita del nuovo libro scritto dal Dottor Giovanni Roberto Tedesco. Il volume offre una visione approfondita e meticolosa sul DryEye e su diagnosi e trattamenti. Frutto di anni di esperienza del Dr. Tedesco e della collaborazione con alcuni tra i maggiori esperti in materia, rappresenta un punto di riferimento per comprendere a fondo questa patologia sempre più diffusa.

Per acquistare una copia👉 https://lnkd.in/dsAxyDd2

05/08/2025

Ophthatec 2025 – La tecnologia incontra la pratica clinica

Il congresso Ophthatec, organizzato dai Dottori Carlo Orione e Dott. Sergio M. Solarino, ha un chiaro obiettivo: far conoscere da vicino le tecnologie più diffuse e utilizzate nelle nostre cliniche oculistiche, tra le quali il Rexon-Eye e la tecnologia .

📅 4-5 Settembre 2025
📍Forte Village Resort - Santa Margherita di P**a (CA)

Un’occasione concreta per approfondire strumenti, metodi e innovazioni che stanno trasformando il modo di curare, attraverso un approccio completo: teoria e pratica.
👉 Per ulteriori informazioni e iscrizioni: https://lnkd.in/dTZXvqma

31/07/2025

Summer break alert

We’ll be taking a summer pause from 4 to 17 August.
We look forward to reconnecting with you soon, recharged and fresh with new energy and exciting news!

Wishing you all a great summer!

$We are excited to invite you to visit us at the upcoming Congress of The European Society of Cataract and Refractive Sur...$

30/07/2025

We are excited to invite you to visit us at the upcoming Congress of The European Society of Cataract and Refractive Surgeons (ESCRS) in Copenhagen

From 12 to 16 September 2025.
Stand: C2.090

We will be unveiling the latest updates from Rexon-Eye Family and you will also have the opportunity to meet renowned international experts sharing their experience with QMR technology.

Don’t miss this chance and secure your appointment 👉 contact@resono.it

$We are excited to invite you to visit us at the The European Society of Cataract and Refractive Surgeons (ESCRS) in Cop...$

29/07/2025

We are excited to invite you to visit us at the The European Society of Cataract and Refractive Surgeons (ESCRS) in Copenhagen.

From 12 to 16 September 2025
Stand: C2.090

We will be unveiling the latest updates from Rexon-Eye Family and you will also have the opportunity to meet renowned international experts sharing their experience with technology.

Don’t miss this chance and secure your appointment 👉 contact@resono.it

15/07/2025

New step forward with Technology

We're excited to share the first randomized, double-masked clinical study on Rexon-Eye, led by Dr. ngamjit kasetsuwan from Thailand, focusing on the treatment of Meibomian Gland Dysfunction (MGD).

Some of the key findings:

• Significant improvement in meibum quality
• Marked reduction in tear IL-6 levels
• Remarkably improved structure and function of Meibomian glands
• Minimal increase in lid temperature (1.50–1.77 °C), stating that the therapy with QMR is not attributed to any thermal effect

The outcomes highlight the broad applicability and the clinical efficacy of QMR technology through a non-invasive approach.

Read the full paper👉https://rexoneye.com/wp-content/uploads/Kasetsuwan_Randomized-double-masked-sham-controlled-trial-of-efficacy-and-safety-of-Rexon-Eye.pdf

Indirizzo

Sandrigo

Orario di apertura

Lunedì	09:00 - 18:00
Martedì	09:00 - 18:00
Mercoledì	09:00 - 18:00
Giovedì	09:00 - 18:00
Venerdì	09:00 - 18:00

Sito Web

https://rexoneye.com/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Resono Ophthalmic Srl pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Resono Ophthalmic Srl:

Scelte rapide

Vuoi che la tua studio sia il Clinica più quotato a Sandrigo?

Digitare

Medicina e salute

REinvent Dry Eye treatment

The company RESONO OPHTHALMIC Srl is a young italian company founded in 2014 whose main activities are focused on the development and marketing of highly innovative therapeutic devices with application in the various scopes of ophthalmology.

The key feature of these devices is the use of Quantum Molecular Resonance (QMR), a patented technique that stimulates natural cellular and tissue regeneration through low-frequency high-frequency electric fields. The first clinical application concerns the dry eye syndrome (DES) with the REXON-EYE instrument (Italian and European patents, the US being registered), a medical device that has already obtained the CE mark.

Clinical trials in Italy and abroad, already completed or in progress, have clearly shown that Rexon-Eye is a safe and effective treatment option to improve subjective and objective symptoms in DES. The benefits of QMR in stimulating natural cell and tissue regeneration are currently being studied for potential application to other eye conditions, paving the way for the development of a family of ophthalmic therapeutic tools based on the QMR.